|
Originally published In Press as doi:10.1074/jbc.M211337200 on January 21, 2003
J. Biol. Chem., Vol. 278, Issue 13, 11661-11669, March 28, 2003
Krüppel-like Factor 4 (KLF4/GKLF) Is a Target of
Bone Morphogenetic Proteins and Transforming Growth Factor 1 in
the Regulation of Vascular Smooth Muscle Cell Phenotype*
Kathryn E.
King,
Valentine P.
Iyemere,
Peter L.
Weissberg, and
Catherine M.
Shanahan
From the University of Cambridge, Department of Medicine,
Addenbrooke's Centre for Clinical Investigation Level 6, Box 110 Addenbrooke's Hospital, Hills Rd.,
Cambridge CB2 2QQ, United Kingdom
Vascular smooth muscle cell (VSMC)
differentiation and phenotypic modulation is characterized by changes
in mRNA expression for smooth muscle (SM) marker contractile
proteins such as -SM actin and SM22 . Transforming growth factor
1 (TGF- 1) is a potent VSMC differentiation factor; however, it is
not known if other TGF- -superfamily members, in particular the bone
morphogenetic proteins (BMPs), modulate VSMC phenotype. Here we
demonstrate that a large subset of TGF- -superfamily members and
their type I receptors are differentially co-expressed as VSMC
phenotype changes during fetal/neonatal development and that BMP2, -4, and -6 reciprocally regulate SM-marker mRNA and protein expression in vitro. BMP2 and BMP6 decrease expression of the SM
markers -SM actin, SM22 , and calponin in rat VSMCs, whereas BMP4
increases their expression. The effects of BMP-2, -4, and -6 on SM
marker gene transcription are mediated through a consensus
TGF- -controlling element, the TCE, which is common to regulatory
regions of SM-marker genes. Moreover, co-treatment experiments revealed
that BMP-2, -4, and -6 each inhibit TGF- 1-modulated increases in
SM22 reporter gene activity. Regardless of whether they positively
or negatively regulate SM marker expression, TGF- 1 and BMP-2, -4, and -6 all induced binding of the Krüppel-like transcription
factor, GKLF/KLF4, to the TGF- control element. Induction of KLF4
was confirmed by immunocytochemistry and Western blotting,
which revealed that a lower molecular weight KLF4 protein is induced
after treatment with TGF- -superfamily members. Taken together, our
results demonstrate that multiple members of the TGF- superfamily
act in concert to modulate VSMC phenotype.
*
This work was supported by British Heart Foundation grants
(to C. M. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
A British Heart Foundation Basic Scientist Lecturer. To
whom correspondence should be addressed. Tel.: 44(1223)-331504; Fax: 44(1223)-331505; E-mail: cs131@mole.bio.cam.ac.uk.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Kawai-Kowase, T. Ohshima, H. Matsui, T. Tanaka, T. Shimizu, T. Iso, M. Arai, G. K. Owens, and M. Kurabayashi
PIAS1 Mediates TGF{beta}-Induced SM {alpha}-Actin Gene Expression Through Inhibition of KLF4 Function-Expression by Protein Sumoylation
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2009;
29(1):
99 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Yu, D. Y. Deng, H. Beppu, C. C. Hong, C. Lai, S. A. Hoyng, N. Kawai, and K. D. Bloch
Bone Morphogenetic Protein (BMP) Type II Receptor Is Required for BMP-mediated Growth Arrest and Differentiation in Pulmonary Artery Smooth Muscle Cells
J. Biol. Chem.,
February 15, 2008;
283(7):
3877 - 3888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lagna, M. M. Ku, P. H. Nguyen, N. A. Neuman, B. N. Davis, and A. Hata
Control of Phenotypic Plasticity of Smooth Muscle Cells by Bone Morphogenetic Protein Signaling through the Myocardin-related Transcription Factors
J. Biol. Chem.,
December 21, 2007;
282(51):
37244 - 37255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. LeClair, T. Durmus, Q. Wang, P. Pyagay, A. Terzic, and V. Lindner
Cthrc1 Is a Novel Inhibitor of Transforming Growth Factor-{beta} Signaling and Neointimal Lesion Formation
Circ. Res.,
March 30, 2007;
100(6):
826 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hayashi, S. Nakamura, W. Nishida, and K. Sobue
Bone Morphogenetic Protein-Induced Msx1 and Msx2 Inhibit Myocardin-Dependent Smooth Muscle Gene Transcription
Mol. Cell. Biol.,
December 15, 2006;
26(24):
9456 - 9470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lagna, P. H. Nguyen, W. Ni, and A. Hata
BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells.
Am J Physiol Lung Cell Mol Physiol,
November 1, 2006;
291(5):
L1059 - L1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bobik
Transforming Growth Factor-{beta}s and Vascular Disorders
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2006;
26(8):
1712 - 1720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zeng, S. Zhuang, J. Gloddek, C.-C. Tseng, G. R. Boss, and R. B. Pilz
Regulation of cGMP-dependent Protein Kinase Expression by Rho and Kruppel-like Transcription Factor-4
J. Biol. Chem.,
June 23, 2006;
281(25):
16951 - 16961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Hruska, S. Mathew, and G. Saab
Bone Morphogenetic Proteins in Vascular Calcification
Circ. Res.,
July 22, 2005;
97(2):
105 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Yu, H. Beppu, N. Kawai, E. Li, and K. D. Bloch
Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells
J. Biol. Chem.,
July 1, 2005;
280(26):
24443 - 24450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yang, L. Long, M. Southwood, N. Rudarakanchana, P. D. Upton, T. K. Jeffery, C. Atkinson, H. Chen, R. C. Trembath, and N. W. Morrell
Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension
Circ. Res.,
May 27, 2005;
96(10):
1053 - 1063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bostrom, A. F. Zebboudj, Y. Yao, T. S. Lin, and A. Torres
Matrix GLA Protein Stimulates VEGF Expression through Increased Transforming Growth Factor-{beta}1 Activity in Endothelial Cells
J. Biol. Chem.,
December 17, 2004;
279(51):
52904 - 52913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, L. Yang, Md. S. Jamaluddin, and D. D. Boyd
The Kruppel-like KLF4 Transcription Factor, a Novel Regulator of Urokinase Receptor Expression, Drives Synthesis of This Binding Site in Colonic Crypt Luminal Surface Epithelial Cells
J. Biol. Chem.,
May 21, 2004;
279(21):
22674 - 22683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y. Pandya, L. I. Talley, A. R. Frost, T. J. Fitzgerald, V. Trivedi, M. Chakravarthy, D. C. Chhieng, W. E. Grizzle, J. A. Engler, H. Krontiras, et al.
Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer
Clin. Cancer Res.,
April 15, 2004;
10(8):
2709 - 2719.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|